![]() EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate. | ![]() Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. | |||
Founding Date | Founding Date 2011 | Founding Date 1990 | Founding Date 2009 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Fremont, US HQ West Wickham, GB | Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Salt Lake City, US HQ Wuxi, CN Walluf, DE Willich, DE Milano, IT Doetinchem, NL Calamba, PH see more |
Employees | Employees 22344% decrease | Employees 303 | Employees 2701% decrease | Employees 2,4004% increase |
Valuation ($) | Valuation ($) 340.9 m | Valuation ($) 157.5 m | Valuation ($) N/A | Valuation ($) 543.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) £51.6m (FY, 2025) | Revenue (est.) £122m (FY, 2018) | Revenue (est.) $844.6m (FY, 2025) |
Cost of goods | Cost of goods $53.9m (FY, 2025) | Cost of goods £19.7m (FY, 2025) | Cost of goods £88.9m (FY, 2018) | Cost of goods $554.1m (FY, 2025) |
Gross profit | Gross profit $15.8m (FY, 2025) | Gross profit £32.1m (FY, 2025) | Gross profit £33.1m (FY, 2018) | Gross profit $290.5m (FY, 2025) |
Net income | Net income ($81.3m) (FY, 2025) | Net income £2.5m (FY, 2025) | Net income £2.5m (FY, 2018) | Net income ($69.9m) (FY, 2025) |

EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
View company
Viapath provides pathology and testing its partners, and NHS and private sector organizations.
View company
Varex Imaging is a developer and manufacturer of X-ray imaging components.
View company